PF-Atlas › Clinical Trials › NCT02278796

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation in Lymphoma Patients

BeEAM · Phase 2

Registry ID

NCT02278796

Phase

Phase 2

Status

Completed

Drug / intervention

BeEAM

Sponsor

Insel Gruppe AG, University Hospital Bern

Start

2015-04

About this trial

BeEAM is evaluated in NCT02278796, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Insel Gruppe AG, University Hospital Bern. Current status: Completed.

View NCT02278796 on ClinicalTrials.gov →

Explore related

All BeEAM trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02278796 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.